Combination therapy with liposomal neuroprotectants and tissue plasminogen activator for treatment of ischemic stroke
Tatsuya Fukuta(University of Shizuoka), Naoto Oku(University of Shizuoka), Mio Namba(University of Shizuoka), Yosuke Yanagida(University of Shizuoka), Hiroyuki Koide(University of Shizuoka), Kosuke Shimizu(Hamamatsu Photonics (Japan)), Tomohiro Asai(University of Shizuoka)
Cited by 120
Related Papers
Recognition, Neutralization, and Clearance of Target Peptides in the Bloodstream of Living Mice by Molecularly Imprinted Polymer Nanoparticles: A Plastic Antibody
|Journal of the American Chemical Society|2010|486
Tyrosine Phosphorylation of β-Catenin and Plakoglobin Enhanced by Hepatocyte Growth Factor and Epidermal Growth Factor in Human Carcinoma Cells
|Cell Communication & Adhesion|1994|417
Arachidonic acid-selective cytosolic phospholipase A2 is crucial in the cytotoxic action of tumor necrosis factor
|Journal of Biological Chemistry|1993|256
The rational design of a synthetic polymer nanoparticle that neutralizes a toxic peptide in vivo
|Proceedings of the National Academy of Sciences|2011|202
A simple procedure for the determination of the trapped volume of liposomes
|Biochimica et Biophysica Acta (BBA) - Biomembranes|1982|184